Products for Research Use Only
RegisterLogin

Sequence-defined antibodies

Recombinant Antibodies for Consistent and Traceable Target Recognition

Recombinant antibodies are produced from defined antibody-encoding sequences using controlled expression systems rather than repeated collection from immunized animals or hybridoma cultures alone. Researchers use them when sequence traceability, renewable production and consistent clone identity are important. Compare products by target, clone, antibody format, host system, isotype, species reactivity, conjugation, validated application, formulation and pack size.

Browse productsSelection guideFAQs

Product catalog

Browse Recombinant Antibodies

Compare product names, catalog numbers, available sizes, pricing, and product specifications.

What are recombinant antibodies?

Recombinant antibodies are generated by expressing known antibody variable-region sequences in a selected production system. They may be supplied as full-length immunoglobulins, fragments or engineered formats. Because the sequence can be preserved and reproduced, the reagent is renewable and its clone identity can remain stable across manufacturing cycles.

These antibodies are used in the same broad research methods as conventional antibodies, including Western blotting, flow cytometry, imaging, immunohistochemistry, ELISA and immunoprecipitation. Recombinant production also enables controlled isotype conversion, direct labeling and engineered fragments. Method suitability still depends on the individual antibody and how its epitope is presented.

Sequence definition can improve traceability but does not automatically establish specificity, affinity or universal application compatibility. Researchers should review clone validation, target state, species reactivity, formulation and expected results. A recombinant version of an antibody may differ from another format because of isotype, expression system, conjugation or manufacturing choices.

Buying and selection guide

How to choose a recombinant antibody

Examine the sequence-defined clone and molecular format together with application validation; recombinant production is a manufacturing attribute, not a complete performance claim.

01

Identify the clone and format

Confirm whether the product is a full-length antibody, Fab, scFv or another engineered format and how that affects detection.

02

Check application validation

Choose evidence from the exact recombinant product rather than assuming performance from a related conventional antibody.

03

Review isotype and host design

Ensure the antibody framework is compatible with secondary detection, Fc-dependent assays and multiplex panels.

04

Confirm species reactivity

Verify target recognition in the experimental organism and review epitope conservation when cross-species use is planned.

05

Compare formulation and conjugation

Check concentration, buffer, carrier proteins, preservatives and attached reporters for compatibility with the assay.

06

Use specificity controls

Validate with positive and negative samples, expected localization or molecular weight and genetic target loss where possible.

Frequently asked questions about recombinant antibodies

These questions explain sequence-defined production, format choices, consistency and validation of recombinant antibody reagents.

What is a recombinant antibody?

A recombinant antibody is produced by expressing a defined antibody-encoding sequence in a controlled host system. It may be a full-length immunoglobulin or an engineered fragment. Because the sequence is known and renewable, the same clone can be reproduced without relying on repeated animal immunization or an unstable source.

How is a recombinant antibody different from a monoclonal antibody?

Monoclonal describes recognition by one clone, while recombinant describes production from a defined sequence. A recombinant antibody is usually monoclonal, but a conventional monoclonal may be produced from hybridoma culture. Recombinant production can improve sequence traceability and renewability, while application performance remains clone-specific.

Are recombinant antibodies more consistent between lots?

They can offer strong lot continuity because production begins from a preserved sequence and controlled expression system. However, formulation, purification, conjugation and manufacturing changes may still affect performance. New lots should be qualified for critical quantitative workflows, especially when the exact format or labeling process changes.

Are recombinant antibodies always more specific?

No. Specificity is determined by the antibody's binding site and validation, not simply by recombinant production. A sequence-defined clone can still cross-react with related proteins or produce background. Use biological controls, expected localization and genetic target-loss samples where possible to assess specificity.

Can recombinant antibodies be converted to another isotype?

Many recombinant sequences can be expressed with different constant regions, enabling isotype or species-framework changes. Such conversion may alter Fc-receptor interactions, secondary detection and functional behavior. The converted format should be validated independently rather than assumed to behave exactly like the original antibody.

What are recombinant antibody fragments used for?

Fragments such as Fab or scFv formats can reduce molecular size, remove some Fc-mediated interactions and improve access in certain assays. They may also change valency, stability and detection requirements. Choose a fragment only when its properties support the experimental objective and the product is validated accordingly.

Can I use a recombinant antibody in the same protocol as a conventional version?

Possibly, but direct substitution should be tested. Changes in isotype, concentration, affinity, formulation or conjugation can alter optimal dilution and background. Compare both reagents on the same positive and negative samples before replacing a validated antibody in a long-term workflow.

What should I report when publishing a recombinant antibody experiment?

Report supplier, catalog number, clone or sequence identifier when available, molecular format, isotype, lot, concentration and protocol. Also document sample preparation, controls and detection reagents. Stating only the target and the word recombinant is not enough to reproduce the experiment.

Related Antibodies categories

Affinity Tag AntibodiesBiosimilar AntibodiesCancer Marker AntibodiesConjugated AntibodiesFlow Cytometry AntibodiesImmunology AntibodiesInfectious Disease AntibodiesIsotype Control AntibodiesMonoclonal AntibodiesNeuroscience Antibodies